rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Domicilium Real Estate Fund III LP

10% owner

Company insider

Files Form 4 as: 10% owner, Eloxx Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
12
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
27 May 2026
Last trade
10 Jun 2026
Last filed
17 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ELOX Eloxx Pharmaceuticals10% owner · Biotechnology · last 10 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 17 Jun 2026ELOX Eloxx PharmaceuticalsBiotechnologySEC FORM 4 Code J—238,422filing
10 Jun 2026filed 17 Jun 2026ELOX Eloxx PharmaceuticalsBiotechnologySEC FORM 4 Code J—361,578filing
10 Jun 2026filed 17 Jun 2026ELOX Eloxx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code J—238,422filing
10 Jun 2026filed 17 Jun 2026ELOX Eloxx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code J—238,422filing
10 Jun 2026filed 17 Jun 2026ELOX Eloxx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code J—361,578filing
10 Jun 2026filed 17 Jun 2026ELOX Eloxx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code J—361,578filing
10 Jun 2026filed 17 Jun 2026ELOX Eloxx PharmaceuticalsBiotechnologySEC FORM 4 Code J—238,422filing
10 Jun 2026filed 17 Jun 2026ELOX Eloxx PharmaceuticalsBiotechnologySEC FORM 4 Code J—361,578filing
27 May 2026filed 5 Jun 2026ELOX Eloxx PharmaceuticalsBiotechnologySEC FORM 4 Code J—113,636 at $0.00filing
27 May 2026filed 5 Jun 2026ELOX Eloxx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code J—113,636filing
27 May 2026filed 5 Jun 2026ELOX Eloxx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code J—113,636filing
27 May 2026filed 5 Jun 2026ELOX Eloxx PharmaceuticalsBiotechnologySEC FORM 4 Code J—113,636 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Steven D. RubinDirector · Director at Eloxx Pharmaceuticals, filing Form 4 there in the last year
Nina S. KjellsonDirector · Director at Eloxx Pharmaceuticals, filing Form 4 there in the last year
Stephen W. WebsterDirector · Director at Eloxx Pharmaceuticals, filing Form 4 there in the last year
Alan Edmund WaltsDirector · Director at Eloxx Pharmaceuticals, filing Form 4 there in the last year
Sumit AggarwalPresident and CEO · President and CEO at Eloxx Pharmaceuticals, filing Form 4 there in the last year